Stig Östlund

måndag, februari 07, 2011

EU trade deal could cost Canadian drug plans billions

Provisions in a new trade deal being negotiated between Canada and the European Union could add about $2.8-billion a year in costs to Canadian drug plans if implemented, a new report warns.

The estimate includes $1.3-billion more for public drug plans and $1.5-billion for private drug plans.

Read more: http://www.theglobeandmail.com/life/health/eu-trade-deal-could-cost-canadian-drug-plans-billions/article1896747/

THE GLOBE AND MAIL

Bloggarkiv